Literature DB >> 22208486

Design and analytical validation of clinical DNA sequencing assays.

Genevieve Pont-Kingdon1, Friederike Gedge, Whitney Wooderchak-Donahue, Iris Schrijver, Karen E Weck, Jeffrey A Kant, Devin Oglesbee, Pinar Bayrak-Toydemir, Elaine Lyon.   

Abstract

CONTEXT: DNA sequencing is the method of choice for mutation detection in many genes.
OBJECTIVES: To demonstrate the analytical accuracy and reliability of DNA sequencing assays developed in clinical laboratories. Only general guidelines exist for the validation of these tests. We provide examples of assay validation strategies for DNA sequencing tests.
DESIGN: We discuss important design and validation considerations.
RESULTS: The validation examples include an accuracy study to evaluate concordance between results obtained by the newly designed assay and analyzed by another method or laboratory. Precision (reproducibility) studies are performed to determine the robustness of the assay. To assess the quality of sequencing assays, several sequence quality measures are available. In addition, assessing the ability of primers to specifically and robustly amplify target regions before sequencing is important.
CONCLUSION: Protocols for validation of laboratory-developed sequencing assays may vary between laboratories. An example summary of a validation is provided.

Mesh:

Substances:

Year:  2012        PMID: 22208486     DOI: 10.5858/arpa.2010-0623-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

1.  Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.

Authors:  Chih-Jian Lih; Robin D Harrington; David J Sims; Kneshay N Harper; Courtney H Bouk; Vivekananda Datta; Jonathan Yau; Rajesh R Singh; Mark J Routbort; Rajyalakshmi Luthra; Keyur P Patel; Geeta S Mantha; Savitri Krishnamurthy; Karyn Ronski; Zenta Walther; Karin E Finberg; Sandra Canosa; Hayley Robinson; Amelia Raymond; Long P Le; Lisa M McShane; Eric C Polley; Barbara A Conley; James H Doroshow; A John Iafrate; Jeffrey L Sklar; Stanley R Hamilton; P Mickey Williams
Journal:  J Mol Diagn       Date:  2017-02-07       Impact factor: 5.568

Review 2.  Assuring the Quality of Next-Generation Sequencing in Clinical Microbiology and Public Health Laboratories.

Authors:  Amy S Gargis; Lisa Kalman; Ira M Lubin
Journal:  J Clin Microbiol       Date:  2016-08-10       Impact factor: 5.948

3.  MycoSNP: A Portable Workflow for Performing Whole-Genome Sequencing Analysis of Candida auris.

Authors:  Ujwal R Bagal; John Phan; Rory M Welsh; Elizabeth Misas; Darlene Wagner; Lalitha Gade; Anastasia P Litvintseva; Christina A Cuomo; Nancy A Chow
Journal:  Methods Mol Biol       Date:  2022

Review 4.  The role of replicates for error mitigation in next-generation sequencing.

Authors:  Kimberly Robasky; Nathan E Lewis; George M Church
Journal:  Nat Rev Genet       Date:  2013-12-10       Impact factor: 53.242

5.  Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Authors:  Neal I Lindeman; Philip T Cagle; Mary Beth Beasley; Dhananjay Arun Chitale; Sanja Dacic; Giuseppe Giaccone; Robert Brian Jenkins; David J Kwiatkowski; Juan-Sebastian Saldivar; Jeremy Squire; Erik Thunnissen; Marc Ladanyi
Journal:  J Thorac Oncol       Date:  2013-07       Impact factor: 15.609

6.  Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

Authors:  Neal I Lindeman; Philip T Cagle; Mary Beth Beasley; Dhananjay Arun Chitale; Sanja Dacic; Giuseppe Giaccone; Robert Brian Jenkins; David J Kwiatkowski; Juan-Sebastian Saldivar; Jeremy Squire; Erik Thunnissen; Marc Ladanyi
Journal:  Arch Pathol Lab Med       Date:  2013-04-03       Impact factor: 5.534

7.  Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.

Authors:  Chih-Jian Lih; David J Sims; Robin D Harrington; Eric C Polley; Yingdong Zhao; Michele G Mehaffey; Thomas D Forbes; Biswajit Das; William D Walsh; Vivekananda Datta; Kneshay N Harper; Courtney H Bouk; Lawrence V Rubinstein; Richard M Simon; Barbara A Conley; Alice P Chen; Shivaani Kummar; James H Doroshow; Paul M Williams
Journal:  J Mol Diagn       Date:  2015-11-18       Impact factor: 5.568

8.  Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.

Authors:  Piotr Rutkowski; Aleksandra Gos; Monika Jurkowska; Tomasz Switaj; Wirginiusz Dziewirski; Marcin Zdzienicki; Konrad Ptaszyński; Wanda Michej; Andrzej Tysarowski; Janusz A Siedlecki
Journal:  Oncol Lett       Date:  2014-05-08       Impact factor: 2.967

9.  Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical Practice.

Authors:  Kang-Yi Su; Jau-Tsuen Kao; Bing-Ching Ho; Hsuan-Yu Chen; Gee-Cheng Chang; Chao-Chi Ho; Sung-Liang Yu
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

Review 10.  Validation of high throughput sequencing and microbial forensics applications.

Authors:  Bruce Budowle; Nancy D Connell; Anna Bielecka-Oder; Rita R Colwell; Cindi R Corbett; Jacqueline Fletcher; Mats Forsman; Dana R Kadavy; Alemka Markotic; Stephen A Morse; Randall S Murch; Antti Sajantila; Sarah E Schmedes; Krista L Ternus; Stephen D Turner; Samuel Minot
Journal:  Investig Genet       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.